Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Revista Medica De Chile
|
September 5, 2008
[General considerations, indications and contraindications for liver transplantation in Chile: a multicenter consensus development document]
Juan Hepp, Rodrigo Zapata, Erwin Buckel, et al.
Revista Medica De Chile
|
December 15, 2006
[Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease]
A Verónica Araya Q, José M Valera M, Jorge Contreras B, et al.
Clinical Science (London, England : 1979)
|
October 15, 2003
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
Luis A Videla, Ramón Rodrigo, Myriam Orellana, et al.
Obesity (Silver Spring, Md.)
|
January 24, 2009
Liver NF-kappaB and AP-1 DNA binding in obese patients
Luis A Videla, Gladys Tapia, Ramón Rodrigo, et al.
Biochimica Et Biophysica Acta
|
September 8, 2009
Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion
Paulina Pettinelli, Talía Del Pozo, Julia Araya, et al.
Annals of Hepatology
|
June 18, 2023
Effect of acute on chronic liver failure over post-transplant survival
Carlos Benítez, Jorge Arnold, Verónica Cambindo, et al.
International Journal of Molecular Sciences
|
April 27, 2024
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz-López, et al.
Annals of Hepatology
|
April 24, 2019
Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator
Luis A Díaz, Blanca Norero, Bárbara Lara, et al.
Oncotarget
|
May 19, 2025
Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma
Leonardo Gomes da Fonseca, Federico Piñero, Margarita Anders, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis
Federico Piñero, Margarita Anders, Carla Bermudez, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Revista Medica De Chile
|
September 5, 2008
[General considerations, indications and contraindications for liver transplantation in Chile: a multicenter consensus development document]
Juan Hepp, Rodrigo Zapata, Erwin Buckel, et al.
Revista Medica De Chile
|
December 15, 2006
[Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease]
A Verónica Araya Q, José M Valera M, Jorge Contreras B, et al.
Clinical Science (London, England : 1979)
|
October 15, 2003
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
Luis A Videla, Ramón Rodrigo, Myriam Orellana, et al.
Obesity (Silver Spring, Md.)
|
January 24, 2009
Liver NF-kappaB and AP-1 DNA binding in obese patients
Luis A Videla, Gladys Tapia, Ramón Rodrigo, et al.
Biochimica Et Biophysica Acta
|
September 8, 2009
Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion
Paulina Pettinelli, Talía Del Pozo, Julia Araya, et al.
Annals of Hepatology
|
June 18, 2023
Effect of acute on chronic liver failure over post-transplant survival
Carlos Benítez, Jorge Arnold, Verónica Cambindo, et al.
International Journal of Molecular Sciences
|
April 27, 2024
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz-López, et al.
Annals of Hepatology
|
April 24, 2019
Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator
Luis A Díaz, Blanca Norero, Bárbara Lara, et al.
Oncotarget
|
May 19, 2025
Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma
Leonardo Gomes da Fonseca, Federico Piñero, Margarita Anders, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis
Federico Piñero, Margarita Anders, Carla Bermudez, et al.
Page
of 9